Semaglutide denied as not medically necessary by Anthem?

Anthem's specific coverage criteria for semaglutide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Anthem Denied Semaglutide as Not Medically Necessary — and How to Build Your Appeal

Medical-necessity denials are the most substantive type of semaglutide denial: Anthem reviewed clinical information and concluded that your specific situation did not meet the criteria in its medical policy. These denials require the most thorough response, but they are also among the most commonly reversed at external review when properly documented.

## Why Medical-Necessity Denials Happen

Anthem's medical policy for semaglutide sets out clinical criteria — typically involving diagnosis confirmation, severity indicators, and prior-treatment history. A denial usually means the submitted documentation was incomplete, the prescriber's notes used clinical language that did not map clearly to Anthem's criteria language, or a required documentation element was missing entirely. The denial is not necessarily a statement that the medication is inappropriate for you — it is often a statement that Anthem could not verify it from the paperwork submitted.

## Your Federal Appeal Rights

• ERISA §503 / ACA §2719 internal appeal: You have the right to a full-and-fair review. Request the specific criteria Anthem applied and the specific reasons the criteria were not met. This information is required to be provided to you.
• External review (ACA §2719): Available after the final internal adverse determination. File within four months. An independent clinician reviewer applies objective clinical standards.
• Expedited review: Available when standard timelines would seriously jeopardize your health or ability to regain maximum function.

## What to Gather

1. Anthem's medical/clinical policy for semaglutide — download from Anthem's website or request in writing. This is your roadmap: every criterion must be addressed. 2. FDA-approved prescribing information — confirms the approved indication and clinical profile. 3. Diagnosis confirmation documentation: Specialist or primary care notes, relevant lab results with dates, and ICD codes establishing the qualifying diagnosis. 4. Clinical severity documentation: Chart entries that quantify disease severity or progression in the language your prescriber uses — not numerical thresholds, but clinical characterizations that map to Anthem's severity criteria. 5. Prior-treatment history: Dates started and stopped, drugs tried, and documented clinical outcomes or reasons for discontinuation. 6. Prescriber medical-necessity letter: This is the most important document. It should take each Anthem criterion and respond to it with chart-specific evidence, explicitly stating how the criterion is met.

## Criteria-Mapping Structure

Create a two-column table. Left column: paste each criterion from Anthem's clinical policy verbatim. Right column: cite the specific chart note, lab date, or treatment record that satisfies it. Submit this table as part of your appeal letter. Reviewers must respond to each line item you raise — an unanswered line item becomes grounds for reversal.

## Key Argument

Medical necessity is a documentation problem as often as it is a clinical one. A complete, criteria-mapped submission transforms the reviewer's task from "does this patient qualify?" to "is there any basis remaining to deny?"